A detailed history of Buckingham Strategic Wealth, LLC transactions in Geron Corp stock. As of the latest transaction made, Buckingham Strategic Wealth, LLC holds 20,280 shares of GERN stock, worth $67,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,280
Previous 20,280 -0.0%
Holding current value
$67,735
Previous $66,000 28.79%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$1.75 - $3.44 $490 - $963
280 Added 1.4%
20,280 $66,000
Q3 2023

Nov 13, 2023

BUY
$2.11 - $3.28 $20,682 - $32,150
9,802 Added 96.12%
20,000 $42,000
Q2 2023

Aug 11, 2023

BUY
$1.97 - $3.69 $20,090 - $37,630
10,198 New
10,198 $32,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.26B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Buckingham Strategic Wealth, LLC Portfolio

Follow Buckingham Strategic Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Strategic Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Strategic Wealth, LLC with notifications on news.